Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

On February 19, 2019, Posted by , In News, By ,, , With Comments Off on Official start of a new research center for individualized cancer immunotherapy: the Helmholtz Institute for Translational Oncology (HI-TRON)

The new Helmholtz Institute for Translational Oncology (HI-TRON Mainz) aims to develop into one of the world’s leading centres for personalised cancer immunotherapy. This is the ambitious goal of the cooperation partners German Cancer Research Center (DKFZ) and Research Institute for Translational Oncology (TRON gGmbH) at the Johannes Gutenberg University…

Opening of the first Fraunhofer Project Center in Israel

On February 19, 2019, Posted by , In News, By , , With Comments Off on Opening of the first Fraunhofer Project Center in Israel

Fraunhofer has been working successfully with research partners in Israel for almost ten years. This cooperation is now being further expanded. The first two Fraunhofer Project Centers at the Hebrew University of Jerusalem in Israel will be open in April Fraunhofer Project Center for Drug Discovery and Delivery – as…

EMBL – Role reversal: RNA controls protein function

On February 15, 2019, Posted by , In News, By , With Comments Off on EMBL – Role reversal: RNA controls protein function

Strands of RNA can bind to proteins to prevent the cell from carrying out autophagy – ‘self-eating’. IMAGE: Tobias Wüstefeld EMBL scientists identify RNA regulating protein behaviour in switch of normal roles Ribonucleic acids (RNAs) perform many important roles within cells, mainly ensuring that proteins are made in the right…

DKFZ – ERC grant for Stefan Pfister: “We must further advance pediatric cancer research”

On January 29, 2019, Posted by , In News, By , , With Comments Off on DKFZ – ERC grant for Stefan Pfister: “We must further advance pediatric cancer research”

KiTZ director Stefan Pfister, professor of pediatric neurooncology at the German Cancer Research Center (DKFZ) and the Heidelberg University Hospital, succeeded in gaining one of the prestigious ERC Consolidator Grants for his project entitled “BRAIN-MATCH”. The goal of BRAIN-MATCH is to characterize normal brain development using molecular-biological methods and to…

“Life Time” – European research for a healthier future

On January 15, 2019, Posted by , In News, By , , With Comments Off on “Life Time” – European research for a healthier future

Our body’s cells are constantly changing. But which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a new transnational and interdisciplinary initiative of leading European researchers, aims to discover. The consortium is jointly coordinated by the Max Delbrück Center in Berlin and…

A faster lane towards effective therapies of childhood brain cancer

On November 6, 2018, Posted by , In News, By ,, , With Comments Off on A faster lane towards effective therapies of childhood brain cancer

Scientists of the „Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ), the German Cancer Consortium (DKTK) and the German Cancer Research Center (DKFZ), in collaboration with colleagues from Seattle, U.S.A., have built a collection of tumor models that can be used to test anticancer drugs for treating childhood brain…

DKFZ/EMBL/Heidelberg University: two ERC Synergy Grants for Heidelberg

On October 29, 2018, Posted by , In News, By , With Comments Off on DKFZ/EMBL/Heidelberg University: two ERC Synergy Grants for Heidelberg

With its “Synergy Grants”, the ERC supports small teams of scientists working together to solve complex research problems, bringing together different techniques and skills across disciplines. “DECODE” Genes are team players. Changes in a genetic make-up often have an effect on the activity of a large number of other genes…

DKFZ: Machine Learning to Accellerate Drug Research

On October 10, 2018, Posted by , In News, By , , With Comments Off on DKFZ: Machine Learning to Accellerate Drug Research

The European Research Council (ERC) is awarding a “proof-of-concept grant” to scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Heidelberg University for the first time to enable them to develop new drugs more cheaply and quickly using image-based analyses. Automated microscopy documents changes in cells after…

Heidelberg University: Highly Organised Process: How Protein Complexes Form in the Cell

On October 8, 2018, Posted by , In News, By , With Comments Off on Heidelberg University: Highly Organised Process: How Protein Complexes Form in the Cell

Heidelberg researchers gain fundamental new insights into synthesis of biologically active complexes. The formation of protein complexes is a highly organised process that does not begin with the “finished” proteins. Studies conducted by researchers at the Center for Molecular Biology of Heidelberg University (ZMBH) and the German Cancer Research Center…

EUROoC network lays the foundation for joint European organ-on-a-chip research

On September 17, 2018, Posted by , In News, By , , With Comments Off on EUROoC network lays the foundation for joint European organ-on-a-chip research

The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is coordinating the establishment of a European research network to promote organ-on-a-chip technology. This enables the replication of human organs on a micro scale and is considered a technology with great potential, among other things for the research of new pharmaceutical…